Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT02046304
Eligibility Criteria:
Inclusion Criteria:
1. Patients with cytologic or histologic proof of Grade II or III resectable soft tissue sarcoma of the extremity or trunk.
2. Patients with both measurable and non-measurable disease. Patients who are S/P pre-referral excision will be eligible.
3. Inclusion of patients with a prior history of malignancy will be at the discretion of the Study Chairman.
4. Patients must have a Zubrod Point Scale of 0 or 1.
5. Absolute neutrophil count must be \> 1,500 cells/mm; platelet count greater than or equal to 100,000 platelets/ml; serum creatinine less than or equal to 1.8 mg/dl, serum glutamate oxaloacetate transaminase (SGOT)/serum glutamate pyruvate transaminase (SGPT) less than or equal to 3 x normal, total bilirubin less then or equal to 1.5 mg/dl.
6. Patients must have no uncontrolled coexisting medical conditions.
7. Women of childbearing potential must not be pregnant or breast feeding and must practice adequate contraception.
8. All patients must sign an informed consent.
Exclusion Criteria:
1\) Patients with a history of prior radiotherapy in the area of the primary tumor or those in whom the anticipated radiation field would include the perineum, scrotum, or vaginal introitus will not be eligible.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02046304
Study Brief:
Protocol Section:
NCT02046304